These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 27050071

  • 21. Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.
    Zhen MC, Wang FQ, Wu SF, Zhao YL, Liu PG, Yin ZY.
    Oncotarget; 2017 Feb 07; 8(6):9466-9475. PubMed ID: 28036295
    [Abstract] [Full Text] [Related]

  • 22. TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.
    Qiu X, Zhu J, Sun Y, Fan K, Yang DR, Li G, Yang G, Chang C.
    Oncotarget; 2015 Jun 20; 6(17):15397-409. PubMed ID: 25980442
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The miR-367-3p Increases Sorafenib Chemotherapy Efficacy to Suppress Hepatocellular Carcinoma Metastasis through Altering the Androgen Receptor Signals.
    Xu J, Lin H, Li G, Sun Y, Chen J, Shi L, Cai X, Chang C.
    EBioMedicine; 2016 Oct 20; 12():55-67. PubMed ID: 27688096
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY, Liu SP, Jiang J, Zhang X, Zhang T.
    Eur Rev Med Pharmacol Sci; 2016 Oct 20; 20(6):1098-108. PubMed ID: 27049263
    [Abstract] [Full Text] [Related]

  • 27. Histone Acetyltransferase 1 Promotes Cell Proliferation and Induces Cisplatin Resistance in Hepatocellular Carcinoma.
    Jin X, Tian S, Li P.
    Oncol Res; 2017 Jul 05; 25(6):939-946. PubMed ID: 27938492
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma.
    Wang M, Wang Z, Zhi X, Ding W, Xiong J, Tao T, Yang Y, Zhang H, Zi X, Zhou W, Huang G.
    Biomed Pharmacother; 2020 Sep 05; 129():110315. PubMed ID: 32554246
    [Abstract] [Full Text] [Related]

  • 30. Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway.
    Qi J, Zhao P, Li F, Guo Y, Cui H, Liu A, Mao H, Zhao Y, Zhang X.
    Int J Clin Exp Pathol; 2015 Sep 05; 8(5):4963-71. PubMed ID: 26191189
    [Abstract] [Full Text] [Related]

  • 31. Downregulation of SSR2 Enhances Hepatocellular Carcinoma Cisplatin Sensitivity via the Hippo Pathway.
    Ye R, Yin L, Ge Y, Zhu X, Xiao Y, Fang C, Liu Q, Zhang H, Li H, Xie B.
    Front Biosci (Landmark Ed); 2024 Aug 21; 29(8):299. PubMed ID: 39206890
    [Abstract] [Full Text] [Related]

  • 32. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX, Qi Y, Zhang J, Liu Y, Xu WH, Xu J, Hu HG, Wu QY, Wang Y, Zhang JP.
    Oncotarget; 2016 Nov 29; 7(48):79544-79556. PubMed ID: 27783993
    [Abstract] [Full Text] [Related]

  • 33. Upregulated HOXC8 Expression Is Associated with Poor Prognosis and Oxaliplatin Resistance in Hepatocellular Carcinoma.
    Xu P, Zhang X, Ni W, Fan H, Xu J, Chen Y, Zhu J, Gu X, Yang L, Ni R, Chen B, Shi W.
    Dig Dis Sci; 2015 Nov 29; 60(11):3351-63. PubMed ID: 26123838
    [Abstract] [Full Text] [Related]

  • 34. Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth.
    Yang WL, Wei L, Huang WQ, Li R, Shen WY, Liu JY, Xu JM, Li B, Qin Y.
    Oncol Rep; 2014 May 29; 31(5):2328-34. PubMed ID: 24676454
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma.
    Feng F, Jiang Q, Cao S, Cao Y, Li R, Shen L, Zhu H, Wang T, Sun L, Liang E, Sun H, Chai Y, Li X, Liu G, Yang R, Yang Z, Yang Y, Xin S, Li BA.
    Biochim Biophys Acta Gen Subj; 2018 Apr 29; 1862(4):1017-1030. PubMed ID: 29369785
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.